The IPO Buzz: Lumexa Imaging Prices IPO at $18.50 Mid-Point
Lumexa Imaging Holdings (LMRI) priced its IPO at $18.50 – the mid-point of its $17.00-to-$20.00 price range – and sold 25 million shares – the number of shares in the prospectus – to raise $462.5 million on Wednesday night, Dec. 10, 2025. At pricing, Lumexa had a market cap of $1.75 billion.
Lumexa’s stock is set to start trading tomorrow – Thursday, Dec. 11, 2025 – on the NASDAQ.
Barclays, J.P. Morgan and Jefferies served as the lead joint book-runners.
As of Sept. 30, 2025, Lumexa Imaging and its affiliates operated the second-largest outpatient imaging center footprint in the United States. It spans 184 centers across 13 states and includes eight joint venture partnerships with health systems.
RadNet (RDNT), the largest U.S. provider of freestanding outpatient diagnostic imaging services, with about 400 centers, was trading today (Wednesday, Dec. 10, 2025) at around $77.69 – near a 52-week high – and that helped increase interest in Lumexa, the IPO pros say.
Lumexa Imaging Holdings (LMRI), based in Raleigh, North Carolina, describes itself as a nationwide provider of diagnostic imaging services that include MRIs, CTs, PET scans, X-rays, ultrasounds and mammograms. The company was founded in 2018 by Charlotte Radiology and Welsh, Carson, Anderson & Stowe, a private equity firm that specializes in investments in private companies in the healthcare and tech sectors. (Incorporated in Delaware)
Paying Down Some Debt
The company estimated net IPO proceeds at about $427 million, the prospectus said.
Lumexa expects to use some of the IPO proceeds to pay down some debt, the prospectus said.
After the IPO, Lumexa’s executive officers and directors, along with private equity firm Welsh, Carson, Anderson & Stowe, will still control about 31 percent of Lumexa’s outstanding common stock.
Financial Snapshot: Net loss of $43.57 million on revenue of $1 billion for the 12 months that ended Sept. 30, 2025
(For more information about this company, please check the IPO Calendar and the individual IPO Profile found on the IPOScoop.com website.)
Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board.
To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message.
Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions.
Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums) is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading.
Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums) is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading.
Source: https://www.iposcoop.com/the-ipo-buzz-lumexa-imaging-prices-ipo-at-18-50-mid-point/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

